META vs TTD

META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across profitability, leverage, and operating efficiency. While the current price of $612.42 trades at a premium to the Graham Number ($213.17) and the growth-based Intrinsic Value ($542.14), the PEG ratio of 0.94 suggests the stock is undervalued relative to its high growth rate. Strong revenue growth (23.8%) and a low forward P/E (17.03) outweigh the bearish technical trend and insider selling. The company's dominant market position and consistent earnings beats support a bullish long-term outlook.

The Trade Desk presents a dichotomy between strong operational efficiency and poor market sentiment. While the Piotroski F-Score of 4/9 indicates stable financial health and the balance sheet is lean with a low Debt/Equity ratio of 0.18, the stock has suffered a catastrophic long-term price decline (-66% over 5 years). Valuation is mixed: it trades significantly above its Graham Number ($10.28) and Intrinsic Value ($16.43), yet its Forward P/E (10.11) and PEG Ratio (0.86) suggest it is undervalued relative to its growth trajectory. The combination of bearish insider activity and poor technical trends offsets the strong margins and analyst 'buy' recommendations.